Humana Inc. (NYSE:HUM) Insider Timothy S. Huval Sells 3,703 Shares

Humana Inc. (NYSE:HUM - Get Free Report) insider Timothy S. Huval sold 3,703 shares of the firm's stock in a transaction dated Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total transaction of $948,930.78. Following the completion of the sale, the insider now owns 8,181 shares of the company's stock, valued at $2,096,463.06. This trade represents a 31.16 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink.

Humana Price Performance

NYSE HUM traded up $9.82 on Friday, hitting $262.47. The stock had a trading volume of 1,373,823 shares, compared to its average volume of 1,126,161. The firm has a 50-day moving average of $272.56 and a 200-day moving average of $314.60. The company has a debt-to-equity ratio of 0.67, a quick ratio of 1.76 and a current ratio of 1.76. Humana Inc. has a 52-week low of $213.31 and a 52-week high of $471.37. The company has a market capitalization of $31.60 billion, a price-to-earnings ratio of 23.25, a price-to-earnings-growth ratio of 2.12 and a beta of 0.53.

Humana (NYSE:HUM - Get Free Report) last issued its quarterly earnings results on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $3.48 by $0.68. Humana had a return on equity of 13.20% and a net margin of 1.18%. The firm had revenue of $29.30 billion during the quarter, compared to the consensus estimate of $28.66 billion. Equities analysts expect that Humana Inc. will post 16.14 EPS for the current year.

Humana Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Tuesday, December 31st will be issued a $0.885 dividend. The ex-dividend date is Tuesday, December 31st. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.35%. Humana's payout ratio is 31.36%.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the stock. Creative Financial Designs Inc. ADV increased its position in shares of Humana by 244.0% in the third quarter. Creative Financial Designs Inc. ADV now owns 86 shares of the insurance provider's stock valued at $27,000 after acquiring an additional 61 shares during the period. Atwood & Palmer Inc. bought a new position in Humana in the third quarter worth about $29,000. Ashton Thomas Securities LLC purchased a new stake in Humana in the third quarter worth about $31,000. Your Advocates Ltd. LLP boosted its position in Humana by 81.8% during the 3rd quarter. Your Advocates Ltd. LLP now owns 100 shares of the insurance provider's stock valued at $32,000 after acquiring an additional 45 shares in the last quarter. Finally, Hollencrest Capital Management purchased a new position in shares of Humana during the 2nd quarter worth approximately $40,000. 92.38% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several analysts have weighed in on HUM shares. Morgan Stanley lifted their price objective on shares of Humana from $288.00 to $301.00 and gave the stock an "equal weight" rating in a research note on Tuesday, December 17th. Leerink Partners downgraded shares of Humana from an "outperform" rating to a "market perform" rating and dropped their price target for the company from $400.00 to $250.00 in a research report on Wednesday, October 2nd. Piper Sandler downgraded Humana from an "overweight" rating to a "neutral" rating and cut their target price for the company from $392.00 to $274.00 in a research report on Thursday, October 3rd. Stephens reissued an "equal weight" rating and issued a $250.00 price objective on shares of Humana in a research note on Wednesday, October 9th. Finally, Leerink Partnrs cut Humana from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, October 2nd. Twenty analysts have rated the stock with a hold rating and six have issued a buy rating to the company's stock. According to MarketBeat.com, the stock has a consensus rating of "Hold" and a consensus target price of $300.50.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.